Amdocs Shares Plunge 39.4% as T-Mobile Dispute Triggers Sharp Cut to Fiscal 2027 Outlook

Amdocs (NASDAQ:DOX) shares plunged 39.4% to $37.83 in premarket trading on Wednesday after the software and services provider issued a substantially weaker fiscal 2027 outlook, citing uncertainty surrounding an escalating contractual dispute with T-Mobile, one of its most important customers.

The company forecast a revenue decline of between 14.3% and 17.9% for fiscal 2027, while adjusted earnings per share are expected to fall between 26% and 30%. The projections overshadowed fourth-quarter 2026 results that were broadly in line with analyst expectations.

Selling pressure intensified after Oppenheimer downgraded Amdocs from Outperform to Perform, while several other analysts reduced their earnings forecasts. A 16.5% decline in the company’s 12-month backlog added to concerns about future revenue visibility.

Fiscal 2027 Guidance Signals Significant Revenue and Earnings Declines

Amdocs issued a substantially weaker financial outlook for fiscal 2027, reflecting uncertainty surrounding its relationship with T-Mobile and the potential impact on future business.

The company expects reported revenue to decline between 14.3% and 17.9% compared with fiscal 2026.

Adjusted earnings per share are projected to fall between 26% and 30% year over year, indicating a significant deterioration in expected profitability.

The guidance represents a sharp change in the company’s near-term financial outlook and raises questions about its ability to offset potential revenue losses from a major customer.

Amdocs provides software and technology services to telecommunications companies, including systems used for billing, customer management and other business operations.

Its exposure to large telecommunications customers means that changes in major commercial relationships can have a substantial impact on revenue and earnings.

The weaker forecast prompted investors to reassess the company’s growth prospects and the risks associated with its customer concentration.

T-Mobile Contract Dispute Creates Uncertainty Over Major Customer Relationship

The principal issue affecting Amdocs’s outlook is an escalating contractual dispute with T-Mobile.

According to the company’s disclosures, both parties have issued notices alleging material breaches of their existing agreements.

The dispute has raised the possibility of contract termination or arbitration, creating uncertainty about the future of a longstanding commercial relationship.

T-Mobile has been a significant contributor to Amdocs’s North American operations, making the potential loss or reduction of business particularly important to the company’s financial outlook.

A termination of existing agreements could affect recurring revenue and future service opportunities.

However, the ultimate outcome remains uncertain, and the exchange of breach notices does not establish that either party’s allegations have been proven.

The dispute could potentially be resolved through negotiations, arbitration or other contractual procedures, although no definitive resolution timetable has been provided.

For investors, the lack of clarity surrounding the relationship represents a significant risk to Amdocs’s fiscal 2027 performance.

Fourth-Quarter Results Meet Expectations but Fail to Offset Guidance Concerns

Amdocs reported fiscal fourth-quarter 2026 results that were broadly consistent with Wall Street expectations.

The company generated revenue of $1.194 billion and non-GAAP earnings per share of $1.98.

Although the quarterly figures were in line with forecasts, they provided little support for the share price following the release of the substantially weaker outlook.

Investors focused instead on the potential impact of the T-Mobile dispute on revenue and profitability over the coming financial year.

The contrast between relatively stable quarterly performance and the projected deterioration in fiscal 2027 highlighted the scale of the uncertainty facing the business.

For companies with substantial recurring service agreements, forward guidance can have a greater influence on market valuations than historical quarterly results.

In Amdocs’s case, the anticipated decline in revenue and earnings significantly altered expectations for its near-term financial performance.

Oppenheimer Downgrades Amdocs to Perform

The company’s disappointing guidance prompted an immediate response from Wall Street analysts.

Oppenheimer downgraded Amdocs shares from Outperform to Perform, citing the weaker fiscal 2027 outlook and uncertainty surrounding the unresolved T-Mobile dispute.

The investment firm also substantially reduced its financial estimates to reflect the company’s revised expectations.

At least three additional analysts lowered their earnings forecasts following the announcement.

The revisions indicated that market expectations for Amdocs’s profitability had deteriorated significantly.

Analysts are now assessing the potential duration of the T-Mobile dispute, the financial implications of any contract changes and the company’s ability to replace affected revenue.

The downgrade added to selling pressure as investors adjusted their valuations to reflect the increased risks.

Twelve-Month Backlog Falls 16.5%

Amdocs also reported a 16.5% year-over-year decline in its 12-month backlog, adding to concerns about the company’s near-term revenue outlook.

The backlog represents contracted business expected to contribute revenue over the following 12 months.

A reduction in this measure can indicate lower expected revenue from existing contractual commitments, although actual results may also depend on new business, contract modifications and the timing of service delivery.

The decline was particularly significant given the uncertainty surrounding the company’s largest customer relationships.

For investors, the reduced backlog suggests that Amdocs has less contracted revenue visibility heading into fiscal 2027.

Combined with the projected decline in annual sales, the backlog contraction reinforced concerns about the company’s ability to maintain its previous revenue levels.

Future contract awards, renewals and developments involving T-Mobile will be important factors in determining whether backlog trends stabilise.

Amdocs Announces $340 Million Acquisition of EIS

Alongside its financial results, Amdocs announced plans to acquire insurance technology company EIS for $340 million.

The acquisition is intended to expand Amdocs’s technology capabilities and provide additional opportunities outside its traditional telecommunications customer base.

EIS operates in the insurance software market, offering technology designed to support insurers’ business operations.

The transaction could help Amdocs diversify its revenue sources and reduce its reliance on telecommunications customers over time.

However, the acquisition also introduces additional financing costs that are expected to weigh on fiscal 2027 profitability.

The financial impact is particularly relevant given the company’s forecast decline in adjusted earnings per share.

Although management views the acquisition as a potential long-term growth opportunity, investors remain focused on the immediate financial pressures associated with the T-Mobile dispute.

The transaction’s longer-term contribution will depend on successful integration and the company’s ability to develop additional business opportunities.

Amdocs Underperforms as Broader US Markets Advance

Amdocs’s 39.4% premarket decline contrasted sharply with gains across the major US equity indexes.

During the same period, the S&P 500 advanced 0.5%, while the Dow Jones Industrial Average gained 1.0% and the Nasdaq rose 0.4%.

The broader market remained relatively stable as investors assessed the results of the US midterm elections.

However, Amdocs shares experienced substantial selling pressure despite the positive market environment.

The divergence highlighted the company-specific nature of the decline, with the weaker financial outlook and contractual uncertainty driving the market reaction.

There was no comparable sector-wide development identified that would explain the magnitude of Amdocs’s losses.

Instead, investors appeared to be reassessing the company’s earnings potential and the risks associated with its relationship with T-Mobile.

Shares Fall Below Previous 52-Week Low

The sharp premarket sell-off pushed Amdocs shares to $37.83, substantially below their previously reported 52-week low of $49.74.

The premarket price represented a decline of approximately 23.9% from that previous low.

The move reflected a significant reassessment of the company’s valuation following its revised fiscal 2027 outlook.

Amdocs’s projected revenue contraction, lower adjusted earnings expectations and declining backlog have increased uncertainty about its near-term financial performance.

The unresolved T-Mobile dispute has also introduced risks that may be difficult for investors to quantify until further information becomes available.

Although the magnitude of the decline could attract attention from investors assessing the company’s longer-term prospects, the outlook remains dependent on developments in its major customer relationships and its ability to stabilise revenue.

T-Mobile Resolution and Revenue Stabilisation Become Key Priorities

The outcome of the contractual dispute with T-Mobile is likely to remain a central consideration for Amdocs shareholders.

A negotiated resolution could provide greater visibility into future revenue, while an extended dispute or contract termination could create additional financial uncertainty.

Investors will also be monitoring whether the company can secure new business to offset potential revenue losses.

The 16.5% decline in 12-month backlog makes future contract activity particularly important.

Meanwhile, the planned acquisition of EIS introduces another element to the company’s strategy as it seeks to expand into additional technology markets.

Management’s ability to control costs, integrate the acquired business and maintain profitability will be important factors in assessing fiscal 2027 performance.

The company’s next financial updates may provide further clarity about the impact of the T-Mobile dispute and the assumptions underlying its revised guidance.

Outlook for Amdocs

Amdocs faces a challenging fiscal 2027 following a sharp deterioration in its financial outlook and growing uncertainty surrounding its relationship with T-Mobile.

The company expects reported revenue to decline between 14.3% and 17.9%, while adjusted earnings per share are projected to fall between 26% and 30%.

Although fourth-quarter 2026 revenue of $1.194 billion and non-GAAP earnings per share of $1.98 were broadly in line with expectations, investors focused on the risks facing the business over the coming year.

Oppenheimer’s downgrade to Perform, additional downward revisions to analyst estimates and a 16.5% decline in the company’s 12-month backlog reinforced concerns about future performance.

The $340 million acquisition of EIS could provide longer-term diversification opportunities, but associated financing costs are expected to add pressure to near-term profitability.

With shares falling 39.4% to $37.83 in premarket trading, investors are reassessing Amdocs’s earnings potential and exposure to major customer contracts.

The resolution of the T-Mobile dispute, stabilisation of its backlog and progress towards achieving its revised financial targets will be central to the company’s outlook.

Amdocs stock price